Future studies that demonstrate a participation of cellular proteins such as GSK3β inviral infections may allow potential use as a specific therapeutic target for thetreatment of infections, capitalising on participation of the kinase in later stepsof the signalling pathway. This evidence concerns the gene GSK3B and infection.